| Molecular formula | C17H22N2O4 |
| Molecular weight | 318.4 g/mol |
| Registered trials | 0 |
| PubChem CID | 180496 |
Key takeaways
- Noopept has no FDA-approved label and is classified as an unapproved research compound.
- No clinical trials for noopept are currently registered.
- Its molecular formula is C17H22N2O4, with a molecular weight of about 318.4.
- No adverse event report data is available for this compound.
What noopept is
Noopept is a synthetic small molecule identified by PubChem CID 180496. It has a molecular formula of C17H22N2O4 and a molecular weight of approximately 318.4. There is no FDA-approved drug label for noopept, so no official indication, mechanism of action, or brand name has been established by regulators.
Regulatory and trial status
Noopept carries an unapproved, research-only status. No clinical trials are currently registered for this compound, so there is no clinical trial evidence available to summarize regarding its effects in humans.
FAQ
No. Noopept does not have an FDA-approved drug label. It is classified as an unapproved research compound with no established approved indication.
No clinical trials for noopept are currently registered in the data reviewed. This means there is no clinical trial evidence available to describe its effects or safety in humans.
Noopept has the molecular formula C17H22N2O4 and a molecular weight of approximately 318.4. It is catalogued under PubChem CID 180496.
No adverse event report data is available for noopept at this time. Without such data, no pattern of reported reactions can be summarized.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 180496
Updated 2026-09-26